Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita. (Q41441615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

epidermolysis bullosa

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ralf J. Ludwig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Anika Kasprick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Xinhua Yu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Julia Scholten

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hendri H Pas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Frank Petersen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Detlef Zillikens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

12 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1462-1470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Emerging treatments for pemphigoid diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Epidermolysis bullosa acquisita: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cell-specific Cre/loxP-mediated recombination in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

The master switch: the role of mast cells in autoimmunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cells in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cells: a cellular link between autoantibodies and inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cells: multifaceted immune cells with diverse roles in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast cell deficiency, a game of kit and mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Widespread immunological functions of mast cells: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Morphologic and Functional Evidence for Release of Mast-Cell Products in Bullous Pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

Identification of the Skin Basement-Membrane Autoantigen in Epidermolysis Bullosa Acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

7 January 2021

Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

7 January 2021

Mast Cells Are Key Promoters of Contact Allergy that Mediate the Adjuvant Effects of Haptens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

7 January 2021

NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

7 January 2021

Cutting Edge: The murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

7 January 2021

The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444769

7 January 2021

Identifiers

DOI

10.1002/EJI.201444769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25678008%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference